Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Mosaic ImmunoEngineering Inc. (CPMV : OTC)
 
 • Company Description   
Mosaic ImmunoEngineering Inc. is a development-stage biotechnology company. It is focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. The company's product pipeline includes MI-O-101. Mosaic ImmunoEngineering Inc., formerly known as Patriot Scientific Corporation, is based in NOVATO, CA.

Number of Employees: 8

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.54 Daily Weekly Monthly
20 Day Moving Average: 199 shares
Shares Outstanding: 7.24 (millions)
Market Capitalization: $3.90 (millions)
Beta: 0.08
52 Week High: $1.13
52 Week Low: $0.21
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 82.43% 72.56%
12 Week -14.19% -28.01%
Year To Date -23.27% -28.13%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
9114 ADAMS AVENUE SUITE 202
-
HUNTINGTON BEACH,CA 92646
USA
ph: 657-208-0890
fax: 760-547-2705
info@mosaicie.com http://www.mosaicie.com
 
 • General Corporate Information   
Officers
Steven King - Chief Executive Officer; President and Director
Paul Lytle - Chief Financial Officer; Director
Robert Baffi - Director
Robert Garnick - Director
Robert Garnick - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 61945M101
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 7.24
Most Recent Split Date: 12.00 (0.00:1)
Beta: 0.08
Market Capitalization: $3.90 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 25.00%
vs. Previous Quarter: -50.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -1,117.89
12/31/24 - -1,351.96
Current Ratio
06/30/25 - -
03/31/25 - 0.02
12/31/24 - 0.03
Quick Ratio
06/30/25 - -
03/31/25 - 0.02
12/31/24 - 0.03
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Book Value
06/30/25 - -
03/31/25 - -0.96
12/31/24 - -0.94
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©